Home › Funds › Wealthspring Capital LLC › DMII

Wealthspring Capital LLC position in DMII

DRUGS MADE IN AMER ACQ II CO · Financials

Wealthspring Capital LLC reported holding 399,150 shares of DMII (DRUGS MADE IN AMER ACQ II CO) in its Q3 2026 13F filing — a position valued at US$4.1M, representing 1.10% of its reported portfolio and ranking #38 among its reported holdings. Wealthspring Capital LLC has disclosed DMII holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)399.15K sh
Reported value held$4.06M
Portfolio Weight1.10%
First reportedQ4 2025
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Wealthspring Capital LLC's DMII position evolved

Wealthspring Capital LLC first disclosed a stake in DMII in Q4 2025 at 408,950 shares (US$4.0M). The position peaked in Q3 2026 at 399,150 shares, worth US$4.1M. Across 4 filings, Wealthspring Capital LLC increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 399,150 shares valued at US$4.1M.

Quarter by quarter

QuarterSharesValueChange
Q4 2025 408.95K $4.05M New
Q1 2026 402.67K $4.01M Reduce
Q2 2026 400.44K $4.03M Reduce
Q3 2026 399.15K $4.06M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DMII and 13F data

DMII (DRUGS MADE IN AMER ACQ II CO) is a Financials company. 71 other funds we track also report a position in DMII — the largest reported positions include Karpus Management, Inc. (US$28.0M), Magnetar Financial LLC (US$27.5M), MMCAP International Inc. SPC (US$27.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DMII

All DMII fund holders →

FAQ

How long has Wealthspring Capital LLC held DMII?

Wealthspring Capital LLC has disclosed DMII holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Wealthspring Capital LLC's current position in DMII?

As of Q3 2026, Wealthspring Capital LLC holds 399.15K shares of DMII (DRUGS MADE IN AMER ACQ II CO), valued at $4.06M, representing 1.10% of its reported portfolio and ranking #38.

Has Wealthspring Capital LLC been buying or selling DMII?

In the latest 13F filing (Q3 2026), Wealthspring Capital LLC held unchanged its position in DMII. The position peaked in Q3 2026 at 399.15K shares.

Which other funds hold DMII?

Other major institutional holders of DMII include Karpus Management, Inc., Magnetar Financial LLC, MMCAP International Inc. SPC, among 71 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.